{"cik":1834105,"taxonomy":"us-gaap","tag":"ShareBasedCompensation","label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","entityName":"Impact     BioMedical, INC.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":19000,"accn":"0001641172-25-001199","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-28"},{"start":"2024-01-01","end":"2024-12-31","val":19000,"accn":"0001641172-25-010276","fy":2025,"fp":"Q1","form":"10-Q","filed":"2025-05-14"},{"start":"2024-01-01","end":"2024-12-31","val":19000,"accn":"0001493152-26-009711","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-11","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":2000,"accn":"0001641172-25-010276","fy":2025,"fp":"Q1","form":"10-Q","filed":"2025-05-14"},{"start":"2025-01-01","end":"2025-03-31","val":2000,"accn":"0001493152-26-022512","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-12","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":4000,"accn":"0001641172-25-023809","fy":2025,"fp":"Q2","form":"10-Q","filed":"2025-08-14"},{"start":"2025-01-01","end":"2025-09-30","val":5000,"accn":"0001493152-25-021286","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-11-07"},{"start":"2025-01-01","end":"2025-12-31","val":13000,"accn":"0001493152-26-009711","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-11","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":1440000,"accn":"0001493152-26-022512","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-12","frame":"CY2026Q1"}]}}